Ranjini Pillay

Nov 12, 2024 | treasuryandrisk.com | Meg Waters |Karen Hom |Tarek El-Yafi |Ranjini Pillay

Bristol Myers Squibb’s (BMS’s) 2019 acquisition of Celgene Corporation was one of the largest pharmaceutical acquisitions in history. Not surprisingly, combining two behemoths in a tightly regulated market sector brought challenges, some of which came to roost in the corporate treasury function.